AKT1 and melanoma: Last but not least, the iNOS pathway has been recently reported to support melanoma growth via the upregulation of the oncogenic PI3K-AKT pathway, and increased intratumoral iNOS activity has also been linked to poor outcomes in melanoma patients [56,57].